Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway

BACKGROUND: Pancreatic cancer is a highly malignant gastrointestinal cancer that can widely metastasize during the early stage of disease, and it is associated with one of the worst prognoses among cancers. In this study, we aimed to investigate the function of Rho GTPase-activating protein 30 (ARHG...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yongping, Hua, Zhiyuan, Zhu, Ye, Wang, Liying, Chen, Fangming, Shan, Ting, Zhou, Yunhai, Dai, Tu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288688/
https://www.ncbi.nlm.nih.gov/pubmed/32536813
http://dx.doi.org/10.1186/s12935-020-01288-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288688/
https://www.ncbi.nlm.nih.gov/pubmed/32536813
http://dx.doi.org/10.1186/s12935-020-01288-7

Ejemplares similares